RxDoctor Payments Data

Lee Bourgeois, MD

Psychiatry · Elkin, NCNPI 1760707848

Payments from drug & device makers

$3,056in general payments, 2019–2025

Across 226 payments — averaging $13.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$924
  • Lundbeck LLC$724
  • AbbVie$669
  • Otsuka America Pharmaceutical, Inc.$231
  • Vanda Pharmaceuticals Inc.$121
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$101
  • plus $285 from 6 others

What the payments were for

  • Food & beverage$3,00998%
  • Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,056 in reported general payments places this provider in the 80th percentile of 1,108 psychiatry providers in North Carolina.

See all psychiatry providers in North Carolina

Medicare billing

Part B allowed, 2024
$67,813
Medicare patients
100
Services billed
701

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate28$216,179
AustedoDeutetrabenazine12$184,886
VraylarCariprazine Hcl107$148,235
CaplytaLumateperone Tosylate55$94,136
RexultiBrexpiprazole52$81,979
FetzimaLevomilnacipran Hcl30$22,539
TrintellixVortioxetine Hydrobromide18$19,169
SunosiSolriamfetol Hcl16$15,917
Hydroxyzine Hcl478$12,885
Vilazodone Hcl80$9,053
Buspirone Hcl412$6,953
Duloxetine Hcl282$6,023
Lamotrigine378$5,401
PristiqDesvenlafaxine Succinate12$5,364
Aripiprazole109$4,269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$48$216,17928 claims
Teva Pharmaceuticals USA, Inc.Austedo$924$184,88612 claims
AbbVieVraylar, Fetzima$669$170,774137 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$101$94,13655 claims
Otsuka America Pharmaceutical, Inc.Rexulti$231$81,97952 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$48$19,16918 claims
Axsome Therapeutics, Inc.Sunosi$88$15,91716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,108 psychiatry providers in North Carolina.

Other psychiatry in Elkin

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →